Synthesis and determination of acute and chronic pain activities of 1-[1-(3-methylphenyl) (tetralyl)]piperidine as a new derivative of phencyclidine via tail immersion and formalin tests

Abstract

Phencyclidine (1-(1-phenylcyclohexyl)piperidine, CAS 956-90-1, PCP, I) and ketamine (2-O-chlorophenyl-2-methylamino-cyclohexan, CAS 1867-66-9, II) revealed some analgesic effects. Some of their derivatives have been synthesized for biological properties studies. Utilizing 1-tetralone as a starting material, 1-[1-(3-methylphenyl)(tetralyl)]piperidine, (PCP-CH₃-tetralyl, III) was synthesized and its analgesic effects were studied on rats via tail immersion (as a model of acute thermal pain) and formalin (as a model of acute chemical and chronic pain) tests and compared with those of ketamine and PCP. The results indicated a marked anti-nociception 2-25 min after ketamine injection, but this analgesic effect lasted for 40 min following PCP-CH₃-tetralyl application in the tail immersion test. However, the data obtained from the formalin test showed that chronic pain could be significantly attenuated by ketamine, PCP and PCP-CH₃-tetralyl.

Key words

CAS 956-90-1 - CAS 1867-66-9 - Ketamine - Phencyclidine - 1-Tetralone derivatives, analgesic effects, formalin test, tail immersion test

• References

• 1 Greifenstein FE, Yoshitake J, De Vaulet M, Gajewski JE. A study of 1-arylcyclohexylamine for anesthesia. Anesth Analg. 1958; 37: 283-4
• 2 Chen G, Ensor CR, Russell D, Bohner B. The pharmacology of 1-(1-phenylcyclohexyl) piperidine. HCl. J. Pharmacol. Exp Ther. 1959; 127: 241-50
• 3 Chen G, Weston JK. The analgesic and anesthetic effects of 1-(1-phenylcyclohexyl) piperidine. HCl on the monkey. Anesth Analg. 1960; 39: 132-7
• 4 Kemp JA, Foster AC, Wong EHF. Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci. 1987; 10: 294-8
• 5 Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 1991; 254 ((5037)) 1515-8
• 6 Kapur S, Seeman P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D (2) and serotonin 5-HT (2) receptors-implications for models of schizophrenia. Mol Psychiatry. 2002; 7 (8) 837-44
• 7 Domino EF, Chodoff P, Corssen G. Pharmacologic effects of Ci-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther. 1965; 6: 279-91
• 8 Brooks WJ, Petit TL, LeBoutillier JC. Effects of chronic administration of NMDA antagonists on synaptic development. Synapse. 1997; 26: 104-13
• 9 Hetman M, Kharebava G. Survival signaling pathways activated by NMDA receptors. Curr Top Med Chem. 2006; 6: 787-99
• 10 Lipton SA. Pathologically activated therapeutics for neuro protection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr Drug Targets. 2007; 8: 621-32
• 11 Schrattenholz A, Soskic V. NMDA receptors are not alone:dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signaling. Curr Top Med Chem. 2006; 6: 663-86
• 12 Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by Nmethyl-aspartate. Br J Pharmacol. 1983; 79: 565-75
• 13 MacDonald JF, Bartlett MC, Mody I, Pahapill P, Reynolds JN, Salter MW et al. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol. 1991; 432: 483-508
• 14 Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol. 1989; 29: 365-402
• 15 Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 1997; 86: 903-17
• 16 Kamenka JM, Chiche B, Goudal R, Geneste P, Vignon J, Vincent JP et al. Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl) piperidine derivatives. J Med Chem. 1982; 25: 431-435
• 17 Al-Deeb OA. Synthesis and analgesic activity of new phencyclidine derivatives. Arzneimittelforschung. 1994; 44 (10) 1141-4
• 18 Ahmadi A, Mahmoudi A. Synthesis and biological properties of 2-hydroxy-1-(1-phenyltetralin)piperidine and someof its intermediates as derivatives of phencyclidine. Arzneimittelforschung. 2005; 55 (9) 528-32
• 19 Al-Deeb OA. New analgesics derived from the phencyclidine analogue thiencyclidine. Arzneimittelforschung. 1996; 46 (5) 505-8
• 20 Ahmadi A, Shafiezadeh M, Fathollahi Y, Darwich MR, Mahmoudi A, Bahmani M et al. Synthesis with improved yield and study on the analgesic effect of 2-hydroxyphencycldine. Arzneimittelforschung. 2005; 55 (3) 172-6
• 21 Geneste P, Kamenka JM, Ung SN, Herrmann P, Goudal R, Trouiller G. Determination conformationnelle de derivesde la phencyclidine en vue d’une correlation structure-active. Eur J Med Chem. 1979; 14: 301-8
• 22 Ahmadi A, Khalili M, Abbassi S, Javadi M, Mahmoudi A, Hajikhani R. Synthesis and study on analgesic effects of 1-[1-(4-methylphenyl)(cyclohexyl)]4-piperidinol and 1-[1-(4-methoxyphenyl)(cyclohexyl)]4-piperidinol as two new phencyclidine derivatives. Arzneimittelforschung. 2009; 59 (4) 202-6
• 23 Kaorv H. O-H stretching absorption and conformation of the ß-methyl derivatives of 1-tetralol, 4-chromanol, 4-thiochromanol, and 4-thiochromanol 1,1-dioxide. Bull Chem Soc Japan. 1974; 47 (10) 2607-8
• 24 Geneste P, Kamenka JM, Dessapt P. Method for stereoselective production of substituted cyclohexylcyanhydrines. Bull Soc Chim Fr. 1980; II: 187-91
• 25 Hamura H, Yoshida M, Shimizu K, Matsukura T, Suzuki H, Narita M et al. Antinociceptive effect of the combinationof pentazocine with morphine in the tail-immersion and scald-pain tests in rats. Jpn J Pharmacol. 2000; 83 (4) 286-92
• 26 Padi SSV, Kulkarni S. K. Minocycline prevents the development of neuropathic pain, but not acute pain: Possible anti-inflammatory and antioxidant mechanisms. Eur JPharmacol. 2008; 601: 79-87
• 27 Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW et al. CB2 cannabinoid receptor mediation of antinociception. Pain. 2006; 122: 3642-
• 28 Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977; 4 (2) 161-74
• 29 Jones LA, Beaver RW, Schmoeger TL, Ort JF, Leander JD. Isolation, identification and synthesis of compounds co-synthesized in the preparation of phencyclidine. J Org Chem. 1981; 46: 3330-3
• 30 Shebley M, Jushchyshyn MI, Hollenberg F. Selective path-ways for the metabolism of phencyclidine by cytochrome P450 2B enzymes: identification of electrophilic methabolites, glutathione and N-acetyl cysteine adducts. Drug Metab Dispos. 2006; 34 (3) 375-83
• 31 Kamenka JM, Hamon J, Vignon J inventors Societe de conseils de recherche et d’applications scientfiques (S.C.R.A.S.) (FR), assignee. Phencyclidine derivatives, preparation method and pharmaceutical compositions containing same. United States patent US 6,342,511B1 2002;
• 32 Qian J, Brown SD, Carlton SM. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Res. 1996; 715: 51-62
• 33 Shimoyama M, Shimoyama N, Gorman AL. Oral ketamine is antinociceptive in the rat formalin test: role of the meta bolite, nor ketamine. Pain. 1999; 81: 85-93
• 34 Rabben T, Skjelbred P, Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-asparate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther. 1999; 289: 1060-
• 35 Bonnefont J, Alloui A, Chapuy E, Clottes E, Eschalier A. Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism. Anesthesiology. 2003; 99 (4) 976-81